glipizide has been researched along with Disease Models, Animal in 11 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin-resistant, obesity-prone mice (KK strain) were treated with pioglitazone, placebo, or the sulfonylurea compound, glipizide, for 2." | 7.73 | Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance. ( Bodary, PF; Eitzman, DT; Jongeward, KL; King, SA; Vargas, FB; Wickenheiser, KJ, 2005) |
| "Insulin-resistant, obesity-prone mice (KK strain) were treated with pioglitazone, placebo, or the sulfonylurea compound, glipizide, for 2." | 3.73 | Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance. ( Bodary, PF; Eitzman, DT; Jongeward, KL; King, SA; Vargas, FB; Wickenheiser, KJ, 2005) |
| "The present study was carried out to investigate the pharmacokinetic and pharmacodynamic drug interaction of irbesartan with glipizide after single and multi dose treatment in normal and hypertensive rat models to evaluate the safety and effectiveness of the combination." | 1.46 | Influence of Single and Multi Dose Treatment of Glipizide on Pharmacokinetics and Pharmacodynamics of Irbesartan in Normal and Hypertensive Rats. ( Anusha, A; Goverdhan, P; Krishna Murthy, B; Narendar, D, 2017) |
| "We further revealed that the anticancer capability of glipizide is not attributed to its antiproliferative effects, which are not significant against various human cancer cell lines." | 1.40 | Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis. ( Cao, L; Ding, Y; He, X; Lan, T; Lee, KK; Li, B; Li, J; Li, W; Qi, C; Song, X; Wang, H; Wang, J; Wang, L; Yang, X; Yang, Y; Ye, Y; Zhang, Q; Zhou, J; Zhou, Q, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 2 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Anusha, A | 1 |
| Narendar, D | 1 |
| Krishna Murthy, B | 1 |
| Goverdhan, P | 1 |
| Qi, C | 1 |
| Zhou, Q | 1 |
| Li, B | 1 |
| Yang, Y | 1 |
| Cao, L | 1 |
| Ye, Y | 1 |
| Li, J | 1 |
| Ding, Y | 1 |
| Wang, H | 1 |
| Wang, J | 1 |
| He, X | 1 |
| Zhang, Q | 1 |
| Lan, T | 1 |
| Lee, KK | 1 |
| Song, X | 1 |
| Zhou, J | 1 |
| Yang, X | 1 |
| Wang, L | 1 |
| Bodary, PF | 1 |
| Vargas, FB | 1 |
| King, SA | 1 |
| Jongeward, KL | 1 |
| Wickenheiser, KJ | 1 |
| Eitzman, DT | 1 |
| Mu, J | 1 |
| Woods, J | 1 |
| Zhou, YP | 1 |
| Roy, RS | 1 |
| Li, Z | 1 |
| Zycband, E | 1 |
| Feng, Y | 1 |
| Zhu, L | 1 |
| Li, C | 1 |
| Howard, AD | 1 |
| Moller, DE | 1 |
| Thornberry, NA | 1 |
| Zhang, BB | 1 |
| Lange, M | 1 |
| Williams, W | 1 |
| Bone, HG | 1 |
| Van Aken, H | 1 |
| Bröking, K | 1 |
| Morelli, A | 1 |
| Hucklenbruch, C | 1 |
| Daudel, F | 1 |
| Ertmer, C | 1 |
| Stubbe, H | 1 |
| Traber, DL | 1 |
| Westphal, M | 1 |
| Hoenig, M | 1 |
| Hall, G | 1 |
| Ferguson, D | 1 |
| Jordan, K | 1 |
| Henson, M | 1 |
| Johnson, K | 1 |
| O'Brien, T | 1 |
| Ettaiche, M | 1 |
| Heurteaux, C | 1 |
| Blondeau, N | 1 |
| Borsotto, M | 1 |
| Tinel, N | 1 |
| Lazdunski, M | 1 |
| Gwilt, M | 1 |
| Henderson, CG | 1 |
| Orme, J | 1 |
| Rourke, JD | 1 |
11 other studies available for glipizide and Disease Models, Animal
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Influence of Single and Multi Dose Treatment of Glipizide on Pharmacokinetics and Pharmacodynamics of Irbesartan in Normal and Hypertensive Rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Bio | 2017 |
Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chick Embr | 2014 |
Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance.
Topics: Animals; Carotid Arteries; Disease Models, Animal; Drug Evaluation, Preclinical; Glipizide; Insulin | 2005 |
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; | 2006 |
Continuously infused glipizide reverses the hyperdynamic circulation in ovine endotoxemia.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Endotoxemia; Endotoxins; Female; Glipizide; | 2007 |
A feline model of experimentally induced islet amyloidosis.
Topics: Amyloid; Amyloidosis; Animals; Cats; Dexamethasone; Diabetes Mellitus, Type 2; Disease Models, Anima | 2000 |
ATP-sensitive potassium channels (K(ATP)) in retina: a key role for delayed ischemic tolerance.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Electroretinography; Gene Expression; Glipi | 2001 |
Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Benzothiazoles; Calcium Channel Blockers; Disease | 1992 |